Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome

This publication has 41 references indexed in Scilit:

• Tegaserod, a 5‐HT₄ receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects
  Alimentary Pharmacology & Therapeutics, 2001
• Tegaserod, a 5‐HT₄ receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation
  Alimentary Pharmacology & Therapeutics, 2001
• A Randomized Controlled Clinical Trial of the Serotonin Type 3 Receptor Antagonist Alosetron in Women With Diarrhea-Predominant Irritable Bowel Syndrome
  Archives of internal medicine (1960), 2001
• Effects of serotonin on intestinal secretion and motility
  Current Opinion in Gastroenterology, 2001
• Alosetron, a 5‐HT₃ receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers
  Alimentary Pharmacology & Therapeutics, 2000
• Irritable bowel syndrome in general practice: prevalence, characteristics, and referral
  Gut, 2000
• Crucial role for 5-HT in cholera toxin but not Escherichia coli heat-labile enterotoxin-intestinal secretion in rats
  Gastroenterology, 1998
• Direct and indirect actions of 5‐hydroxytryptamine on the discharge of mesenteric afferent fibres innervating the rat jejunum
  The Journal of Physiology, 1998
• 5‐HT activates neural reflexes regulating secretion in the guinea‐pig colon
  Neurogastroenterology & Motility, 1997
• ORGANIC AND FUNCTIONAL DISORDERS IN 2000 GASTROENTEROLOGY OUTPATIENTS
  The Lancet, 1983